TYPES AND AMOUNT OF DIETARY FAT AND COLON CANCER
膳食脂肪和结肠癌的类型和数量
基本信息
- 批准号:2693698
- 负责人:
- 金额:$ 24.54万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1993
- 资助国家:美国
- 起止时间:1993-09-30 至 2001-06-30
- 项目状态:已结题
- 来源:
- 关键词:SDS polyacrylamide gel electrophoresis alkyltransferase azo compounds caloric dietary content colon neoplasms diacylglycerols dietary lipid eicosanoid metabolism feces analysis gas chromatography intestinal mucosa isozymes laboratory rat marine animal oil neoplastic process nutrition related neoplasm /cancer nutrition related tag omega 3 fatty acid phospholipase C prostaglandin endoperoxide synthase protein kinase C tumor promoters vegetable oils western blottings
项目摘要
Epidemiologic and animal model studies suggest that dietary intake of
certain types of fat plays a role in the risk of colon cancer
development. The long term objective is to understand the modulating
effects of amount and types of fat differing in fatty acid composition
in colon tumor promotion and progression. Specifically, it is proposed
to investigate the mechanism(s) of types and amount of dietary fat such
as corn oil (CO) and menhaden fish oil (FO) rich in omega-6 and omega-3
fatty acids, respectively and mixed lipid high in saturated fats.
Recent studies indicate that high intake of certain dietary fats has
been associated with an alteration in the production of secondary bile
acids, diacylglycerols (DAG) and fatty acids in the colonic contents
which could enter the colonic mucosa and activate several cellular
events including protein kinase C (PKC), arachidonic acid metabolism and
ras p21, to cite a few. These biochemical and molecular events induced
by types and amount of dietary fat became a basis to conduct in-depth
studies. Specifically, it is proposed to determine the effect of diets
high and low in CO and high in FO and mixed lipids on the production of
DAG by the gut microflora, fatty acid composition of colonic luminal
(fecal) DAGs, colonic mucosal and tumor up-regulation and down-
regulation of PKC isozymes, cyclooxygenase isozymes, and farnesyl
protein transferase during promotion and progression stages of colon
carcinogenesis. At 5 weeks of age, groups of male F344 rats will be fed
low-fat AIN-76A diet containing CO (LFCO). At 7 weeks of age, groups
of animals will be treated with two weekly s.c. doses of azoxymethane
(AOM) or normal saline (vehicle and one day later, they will be
transferred to high fat diets containing CO (HFCO) or FO (HFF0). One
group will be continued on LFCO diet. Then the groups of animals will
be sacrificed at weeks 1, 12, 36 and 50 after AOM or saline treatment.
Prior to sacrifice, daily stool samples for one week will be collected
from each animal and analyzed for fecal DAG mass and their fatty acid
composition. Cecal contents will be used to determine the production
of DAG by intestinal microflora. Colon mucosa harvested at weeks 1, 12,
36 and 50 and colon tumors will be used to determine the isoforms of
PKC, cyclooxygenase 1 and 2, and farnesyl-protein transferase. These
biochemical and molecular parameters of animals treated with AOM or
saline and fed the experimental diets will be analyzed statistically to
determine the significance of difference. It is hoped that the results
generated from the proposed mechanistic study will strengthen the
rationale for primary and secondary prevention of colon cancer through
dietary modulation.
流行病学和动物模型研究表明,
某些类型的脂肪在结肠癌的风险中起作用
发展 长期目标是了解调制
脂肪酸组成不同的脂肪的量和类型的影响
在结肠肿瘤的促进和进展中。具体而言,建议
研究膳食脂肪的种类和数量的机制,
玉米油(CO)和鲱鱼油(FO)富含omega-6和omega-3
脂肪酸,分别和混合脂质高饱和脂肪。
最近的研究表明,某些膳食脂肪的高摄入量
与次级胆汁产生的改变有关
结肠内容物中的酸、二酰基甘油(DAG)和脂肪酸
它可以进入结肠粘膜并激活几种细胞
包括蛋白激酶C(PKC)、花生四烯酸代谢和
例如ras p21。 这些生物化学和分子事件导致
以膳食脂肪的种类和量为依据,
问题研究具体而言,建议确定饮食的影响
高和低的CO和高的FO和混合脂质的生产
DAG由肠道菌群、结肠腔脂肪酸组成
(粪便)DAG、结肠粘膜和肿瘤上调和下调
PKC同工酶、环氧合酶同工酶和法呢基的调节
结肠促进和进展阶段的蛋白质转移酶
致癌作用 在5周龄时,将各组雄性F344大鼠喂食
低脂肪AIN-76 A饮食含有CO(LFCO)。 在7周龄时,各组
的动物将用每周两次的s.c.氧化偶氮甲烷剂量
(AOM)或生理盐水(媒介物),一天后,将它们
转移到含有CO(HFCO)或FO(HFF 0)的高脂肪饮食。一
组将继续LFCO饮食。 然后动物群体
在AOM或盐水处理后第1、12、36和50周处死。
处死前,将采集一周的每日粪便样本
并分析粪便DAG质量及其脂肪酸
混合物. 盲肠内容物将用于确定生产
DAG的肠道菌群。 在第1、12、14周采集结肠粘膜
36和50以及结肠肿瘤将用于确定
PKC、环氧合酶1和2以及法尼基蛋白转移酶。 这些
用AOM处理的动物的生物化学和分子参数,或
将对生理盐水和喂食实验饮食的动物进行统计学分析,
确定差异的显著性。 希望结果
从拟议的机制研究产生的将加强
结肠癌一级和二级预防的基本原理,
饮食调节
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Bandaru S. Reddy其他文献
Prevention of colon cancer by low doses of celecoxib, a cyclooxygenase inhibitor, administered in diet rich in omega-3 polyunsaturated fatty acids.
通过在富含 omega-3 多不饱和脂肪酸的饮食中服用低剂量塞来昔布(一种环氧合酶抑制剂)来预防结肠癌。
- DOI:
- 发表时间:
2005 - 期刊:
- 影响因子:11.2
- 作者:
Bandaru S. Reddy;J. Patlolla;B. Simi;S. H. Wang;C. Rao - 通讯作者:
C. Rao
Effect of bile acids and dietary fat on large bowel carcinogenesis in animal models
胆汁酸和膳食脂肪对动物模型大肠癌发生的影响
- DOI:
10.1007/bf02773665 - 发表时间:
2007 - 期刊:
- 影响因子:0
- 作者:
T. Narisawa;Bandaru S. Reddy;J. Weisburger - 通讯作者:
J. Weisburger
Amino Acid Composition of Cecal Contents and Feces in Germfree and Conventional Rabbits
- DOI:
10.1093/jn/101.10.1423 - 发表时间:
1971-10-01 - 期刊:
- 影响因子:
- 作者:
Tsutomu Yoshida;Julian R. Pleasants;Bandaru S. Reddy;Bernard S. Wostmann - 通讯作者:
Bernard S. Wostmann
Possible mechanisms by which pro- and prebiotics influence colon carcinogenesis and tumor growth.
- DOI:
10.1093/jn/129.7.1478s - 发表时间:
1999-07 - 期刊:
- 影响因子:0
- 作者:
Bandaru S. Reddy - 通讯作者:
Bandaru S. Reddy
Colon Cancer Prevention Experimental Colon Carcinogenesis: Implications for Human Preventive Potential of Wheat Bran Fractions against
结肠癌预防实验性结肠癌发生:麦麸成分对人类预防结肠癌的潜力的影响
- DOI:
- 发表时间:
2013 - 期刊:
- 影响因子:0
- 作者:
Bandaru S. Reddy;Y. Hirose;L. Cohen - 通讯作者:
L. Cohen
Bandaru S. Reddy的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Bandaru S. Reddy', 18)}}的其他基金
CHEMOPREVENTION OF COLON CANCER BY SELECTED ORGANOSELENIUM COMPOUNDS
选定的有机硒化合物对结肠癌的化学预防
- 批准号:
6334953 - 财政年份:2000
- 资助金额:
$ 24.54万 - 项目类别:
CHEMOPREVENTION OF COLON CANCER BY SELECTED ORGANOSELENIUM COMPOUNDS
选定的有机硒化合物对结肠癌的化学预防
- 批准号:
6203138 - 财政年份:1999
- 资助金额:
$ 24.54万 - 项目类别:
CHEMOPREVENTION OF COLON CANCER BY SELECTED ORGANOSELENIUM COMPOUNDS
选定的有机硒化合物对结肠癌的化学预防
- 批准号:
6102426 - 财政年份:1998
- 资助金额:
$ 24.54万 - 项目类别:
POTENTIAL CHEMOPREVENTIVE AGENTS EFFECTS ON AZOXY-
潜在的化学预防剂对 AZOXY- 的影响
- 批准号:
2720700 - 财政年份:1997
- 资助金额:
$ 24.54万 - 项目类别:
COX-2 Inhibitor and N-3PUFA in Colon Cancer Prevention
COX-2 抑制剂和 N-3PUFA 在结肠癌预防中的作用
- 批准号:
6954261 - 财政年份:1993
- 资助金额:
$ 24.54万 - 项目类别:
COX-2 Inhibitor and N-3PUFA in Colon Cancer Prevention
COX-2 抑制剂和 N-3PUFA 在结肠癌预防中的作用
- 批准号:
7088932 - 财政年份:1993
- 资助金额:
$ 24.54万 - 项目类别:
COX-2 Inhibitor and N-3PUFA in Colon Cancer Prevention
COX-2 抑制剂和 N-3PUFA 在结肠癌预防中的作用
- 批准号:
6771030 - 财政年份:1993
- 资助金额:
$ 24.54万 - 项目类别:
相似海外基金
O6-Alkylguanine-DNA Alkyltransferase Repair of Modified Pyrimidines
O6-烷基鸟嘌呤-DNA 烷基转移酶修复修饰的嘧啶
- 批准号:
498189-2016 - 财政年份:2016
- 资助金额:
$ 24.54万 - 项目类别:
University Undergraduate Student Research Awards
MICRO-PET IMAGING OF ALKYLGUANINE-DNA ALKYLTRANSFERASE (AGT)
烷基鸟嘌呤-DNA 烷基转移酶 (AGT) 的显微 PET 成像
- 批准号:
7358332 - 财政年份:2006
- 资助金额:
$ 24.54万 - 项目类别:
Imaging of O6-Alkylguanine-DNA Alkyltransferase
O6-烷基鸟嘌呤-DNA 烷基转移酶的成像
- 批准号:
6942764 - 财政年份:2002
- 资助金额:
$ 24.54万 - 项目类别:
Imaging of O6-Alkylguanine-DNA Alkyltransferase
O6-烷基鸟嘌呤-DNA 烷基转移酶的成像
- 批准号:
6542181 - 财政年份:2002
- 资助金额:
$ 24.54万 - 项目类别:
Imaging of O6-Alkylguanine-DNA Alkyltransferase
O6-烷基鸟嘌呤-DNA 烷基转移酶的成像
- 批准号:
6793233 - 财政年份:2002
- 资助金额:
$ 24.54万 - 项目类别:
Imaging of O6-Alkylguanine-DNA Alkyltransferase
O6-烷基鸟嘌呤-DNA 烷基转移酶的成像
- 批准号:
6667313 - 财政年份:2002
- 资助金额:
$ 24.54万 - 项目类别:
UB-PROTEOLYSIS OF ALKYLTRANSFERASE IN GLIOMA THERAPY
神经胶质瘤治疗中烷基转移酶的 UB 蛋白水解
- 批准号:
6489201 - 财政年份:1998
- 资助金额:
$ 24.54万 - 项目类别:
UB-PROTEOLYSIS OF ALKYLTRANSFERASE IN GLIOMA THERAPY
神经胶质瘤治疗中烷基转移酶的 UB 蛋白水解
- 批准号:
2856463 - 财政年份:1998
- 资助金额:
$ 24.54万 - 项目类别:
UB-PROTEOLYSIS OF ALKYLTRANSFERASE IN GLIOMA THERAPY
神经胶质瘤治疗中烷基转移酶的 UB 蛋白水解
- 批准号:
6137608 - 财政年份:1998
- 资助金额:
$ 24.54万 - 项目类别:
UB-PROTEOLYSIS OF ALKYLTRANSFERASE IN GLIOMA THERAPY
神经胶质瘤治疗中烷基转移酶的 UB 蛋白水解
- 批准号:
6342034 - 财政年份:1998
- 资助金额:
$ 24.54万 - 项目类别: